Abstracts and Articles

Impact of Non-Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha.

Li Chujing (C);Lin Lihua (L);Zhou Pei (P);Cai Haiyi (H);Liu Songlian (S);Chen Xiaoyuan (X);Lu Aiqi (A);Li Bo (B);Wang Yaping (Y);Luo Chuanghua (C);Li Jianping (J);Guan Yujuan (Y);Xie Zhiwei (Z)

Pre-TIPS Diastolic Dysfunction as a Predictor of Post-TIPS Outcomes in Patients With Cirrhosis.

Bommena Shoma (S);Patel Jason (J);Rangan Pooja (P);Fallon Michael B (MB)

Trimester-Specific Impacts of Steatotic Liver Disease on Adverse Pregnancy Outcomes: A Retrospective Cohort Study.

Yang Lei (L);Yang Shuhan (S);Wang Youxin (Y);Hebestreit Antje (A);Wang Mingyue (M);Yang Yifan (Y);Wu Yuying (Y);Long Yan (Y);Wang Hui (H)

Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet).

Fridén Michael (M);Rosqvist Fredrik (F);Kullberg Joel (J);Berglund Lars (L);Vessby Johan (J);Martinell Mats (M);Carlsson Per-Ola (PO);Hulthe Johannes (J);Johansson Lars (L);Ahmad Nouman (N);Johansson Hans-Erik (HE);Rorsman Fredrik (F);Sundström Johan (J);Lind Lars (L);Landberg Rikard (R);Orho-Melander Marju (M);Ahlström Håkan (H);Risérus Ulf (U)

Hepatic steatosis detected on low-dose computed tomography in high-risk participants of a lung cancer screening program: a retrospective observational study.

Bonney Asha (A);Chua Michelle (M);Pascoe Diane (D);McCusker Mark W (MW);Steinfort Daniel (D);Sood Siddharth (S);Marshall Henry (H);Brims Fraser (F);McWilliams Annette (A);Stone Emily (E);Fogarty Paul (P);Fong Kwun M (KM);Lam Stephen (S);Manser Renee (R)

Developing a non-invasive algorithm for the diagnosis of steatotic liver disease in primary healthcare: a retrospective cohort study.

Spencer-Sandino Maria (M);Godoy Franco (F);Alvares Danilo (D);Elorrieta Felipe (F);Argirion Ilona (I);Koshiol Jill (J);Vargas Claudio (C);Marco Claudia (C);Garrido Macarena (M);Cabrera Daniel (D);Arab Juan Pablo (JP);Arrese Marco (M);Huidobro Laura (L);Barrera Francisco (F);Ferreccio Catterina (C)

Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations.

Song Sherlot Juan (SJ);Yoon Eileen Laureal (EL);Wong Vincent Wai-Sun (VW);Jo Ae Jeong (AJ);Wong Grace Lai-Hung (GL);Lai Jimmy Che-To (JC);Jun Dae Won (DW);Yip Terry Cheuk-Fung (TC)

Increased Risk of Postoperative Complications in Non-Alcoholic Cirrhosis Versus Non-Alcoholic Fatty Liver Disease Following Total Knee Arthroplasty: A National Matched Cohort Study.

Sasaki Jared (J);Hand Catherine (C);Bohn Camden (C);Angotti Morgan (M);Shinn Daniel (D);Lemme Nicholas (N);Forsythe Brian (B)

Association between atherogenic index of plasma and various metabolic conditions: an umbrella review on meta-analyses.

Rashidian Pegah (P);Mirchandani Mohit (M);Somu Kavya Priya (KP);Jala Saisree Reddy Adla (SRA);Mahapatro Abinash (A);Hashemi Seyyed Mohammad (SM);Nasrollahizadeh Amir (A);Joukar Farahnaz (F);Eshraghi Reza (R);Letafatkar Negin (N);Amini-Salehi Ehsan (E)

Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study.

Gungabissoon Usha (U);Hunnicutt Jake (J);McDermott Eleanor J (EJ);Lovley Andrew (A);Frazer Monica S (MS);LaGasse Kaitlin M (KM);Kosinski Mark (M);McCausland Kristen L (KL);McGirr Ashleigh (A);Smith Helen T (HT);Hirschfield Gideon M (GM);Trivedi Palak (P)

Association between obesity and intraoperative hypothermia in women undergoing caesarean delivery: results from a prospective cohort study.

Qin Pei-Pei (PP);Zhao Shi-Yue (SY);Zou Bing-Yu (BY);Zhuoma Lamu (L);Liu Ling (L);Min Su (S);Wei Ke (K)

Efficacy and safety of statins for nonalcoholic/metabolic dysfunction-associated fatty liver diseases: a systematic review and meta-analysis.

Fang Xiaohui (X);Yin Yuhang (Y);Wu Qinke (Q);Chai Lu (L);Guo Yifan (Y);Tong Zhenhua (Z);Méndez-Sánchez Nahum (N);Qi Xingshun (X)

Effects of glucagon-like peptide-1 receptor agonists on patients with metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and sequential meta-analysis.

Wang Mei-Jun (MJ);Jiang Yu-Nuo (YN);Li Pei-Pei (PP);Wu Yuan-Jie (YJ)

Comparative efficacy of different diet modalities on metabolic profiles and liver functions in metabolic dysfunction-associated fatty liver disease: a network meta-analysis.

Zou Jiahui (J);Tian Fei (F);Cui Shuqing (S);Hou Jing (J);Li Zhenhua (Z);Wei Yaochen (Y);Cui Haozhe (H);Li Yunpeng (Y);Zhou Shuanghao (S);He Zechao (Z);Ma Xiangming (X)

Metabolic dysfunction-associated steatohepatitis is the leading indication for adult liver transplantation in Saudi Arabia.

Alqahtani Saleh A (SA);AlMuhaidib Shadan (S);Raptis Dimitri A (DA);Al-Hamoudi Waleed K (WK);Reddy K Rajender (KR);Broering Dieter C (DC);Alghamdi Saad A (SA); ()

Screening and management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Geary Anne (A)

Etiology of cirrhosis is associated with risk of hepatic decompensation and hepatocellular carcinoma.

Ng Michelle (M);Bardhi Olgert (O);Lai Krystal (K);Koo Eden (E);Yekkaluri Sruthi (S);Bass Kevin (K);Bhamra Guruveer (G);Danpanichkul Pojsakorn (P);Quirk Lisa (L);Yang Ju Dong (JD);Louissaint Jeremy (J);Kerr Thomas A (TA);Singal Amit G (AG)

Meta-analysis of clinically available pharmacotherapy of biopsy confirmed metabolic dysfunction associated steatohepatitis (MASH).

Wood Emily (E);Akande Rukayat (R);Iqbal Iqra (I);Albert Stewart G (SG)